CClinicalTrials.gg
CompletedNCT04653402ENDUpdated Jul 25, 2023

Determine the Efficacy of Closed Suction Drain After Hydrocelectomy. (END Trial)

An interventional study of Hydrocelectomy surgery in Hydrocele of Tunica Vaginalis, sponsored by All India Institute of Medical Sciences, Bhubaneswar. Completed at 1 site in India. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-25.

Sponsored by All India Institute of Medical Sciences, Bhubaneswar · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Study summary

There is no clear consensus regarding the benefits of putting a closed suction drain after eversion of the sac in a hydrocele of the tunica vaginalis testis. Our study will find out the benefits if at all of a closed suction drain in hydrocele surgery. The potential complications expected after hydrocelectomy surgery are bleeding, infection, redness, and pain. There is no such trial to date to determine the benefits of putting a closed suction drain after hydrocelectomy surgery.

Read the detailed description

Study objectives:

  1. Primary:

    To compare the postoperative complication rates of hematoma, skin edema and surgical site infection after hydrocelectomy, between patients with or without a closed suction drain (CSD).

  2. Secondary:

To compare postoperative pain (testalgia) between the two groups of patients.

Study setting: All patients over 18 years of age attending the outpatient department of General Surgery at AIIMS, Bhubaneswar with the diagnosis of idiopathic hydrocele and planned for elective surgery.

Total Sample Size = 60 (30 in each arm)

02

Conditions studied

  • Hydrocele of Tunica Vaginalis

Keywords

  • Hydrocele
  • Drain
  • Surgery
  • Complications
  • Hydrocelectomy
  • Hematoma
  • Infection
03

In context

Lead sponsor

All India Institute of Medical Sciences, Bhubaneswar is the lead sponsor of 59 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • All patients over 18 years of age diagnosed with primary hydrocele by clinical and ultrasonographic confirmation, undergoing hydrocelectomy surgery.

Exclusion criteria

Exclusion Criteria:

  • Patient not giving consent to participate
  • Patients with ASA (American Society of Anaesthesiology) grade 3 \& 4
  • Patients with congenital or secondary hydrocele
  • Patients with recurrent disease, pyocele or filarial scrotum
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Study arm 1

    Placing a closed suction drain after hydrocelectomy for primary vaginal hydrocele

    Device: Hydrocelectomy surgery

  • Active comparator
    Study arm 2

    Not placing a drain after hydrocelectomy in primary vaginal hydrocele

    Device: Hydrocelectomy surgery

Interventions

  • DeviceHydrocelectomy surgery

    The standardized hydrocelectomy operation i.e. Eversion of the TVT sac

06

What researchers measure

Primary outcomes

  1. Skin edema

    Boggy swelling of scrotal wall

    Time frame: Post operative period of 1 month

  2. Hematoma

    Post-operative swelling of scrotum with skin discolouration and oozing of blood through the incision site

    Time frame: Post operative period of 1 month

  3. Surgical site infection

    Seropurulent discharge from the incision site with systemic signs of infection like fever, tachycardia and local signs like edema, redness and tenderness

    Time frame: Post operative period of 1 month

Secondary outcomes

  1. Testalgia

    Visual Analog Scale scoring on a 100 mm length scale ( low score with no pain to higher scores with worst imaginable pain) for acute and sub acute testalgia

    Time frame: post operative period of 1 month

07

Study locations

1 site
  • All India institute of medical sciences
    Bhubaneswar, Odisha 751019, India
08

References and documents

Publications

  • Dagur G, Gandhi J, Suh Y, Weissbart S, Sheynkin YR, Smith NL, Joshi G, Khan SA. Classifying Hydroceles of the Pelvis and Groin: An Overview of Etiology, Secondary Complications, Evaluation, and Management. Curr Urol. 2017 Apr;10(1):1-14. doi: 10.1159/000447145. Epub 2017 Mar 30. PubMed 28559772 ↗
  • Tsai L, Milburn PA, Cecil CL 4th, Lowry PS, Hermans MR. Comparison of Recurrence and Postoperative Complications Between 3 Different Techniques for Surgical Repair of Idiopathic Hydrocele. Urology. 2019 Mar;125:239-242. doi: 10.1016/j.urology.2018.12.004. Epub 2018 Dec 12. PubMed 30552941 ↗
  • Agbakwuru EA, Salako AA, Olajide AO, Takure AO, Eziyi AK. Hydrocelectomy under local anaesthesia in a Nigerian adult population. Afr Health Sci. 2008 Sep;8(3):160-2. PubMed 19357743 ↗
  • Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016 Jun;25(3):1057-73. doi: 10.1177/0962280215588241. Epub 2015 Jun 19. PubMed 26092476 ↗
  • Patil V, Shetty SM, Das S. Common and Uncommon Presentation of Fluid within the Scrotal Spaces. Ultrasound Int Open. 2015 Nov;1(2):E34-40. doi: 10.1055/s-0035-1555919. Epub 2015 Nov 6. PubMed 27689151 ↗

Individual participant data

Plan to share: Yes — Participant information sheet and participant consent form and study protocol.

Supporting information: Study protocol, Icf

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04653402
Lead sponsor
All India Institute of Medical Sciences, Bhubaneswar
Responsible party
Dr. Prakash Kumar Sasmal (Additional Professor,Dept of General Surgery, All India Institute of Medical Sciences, Bhubaneswar) — Principal investigator
First posted
Dec 4, 2020
Start date
Jan 1, 2021
Primary completion
Jun 30, 2023
Completion
Jul 15, 2023
Last update
Jul 25, 2023

Study contacts

Prakash K. Sasmal, MS,FNB,FAIS
principal investigator · All India Institute of Medical Sciences, Bhubaneswar, INDIA

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion